MiNK Therapeutics, Inc. - Stock (INKT)

CUSIP: 603693102

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Stock
Total 13F shares
779,947
Share change
-556,954
Total reported value
$1,756,000
Price per share
$2.25
Number of holders
15
Value change
-$2,561,337
Number of buys
8
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 603693102?
CUSIP 603693102 identifies INKT - MiNK Therapeutics, Inc. - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MiNK Therapeutics, Inc. - Stock (INKT) as of Q1 2022

As of 31 Mar 2022, MiNK Therapeutics, Inc. - Stock (INKT) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 779,947 shares. The largest 10 holders included Sofinnova Investments, Inc., Artal Group S.A., BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, NEW YORK STATE COMMON RETIREMENT FUND, and UBS Group AG. This page lists 15 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.